1 study found for:    16273092 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Terminated
Has Results
Study Using a Genomic Predictor of Platinum Resistance to Guide Therapy in Stage IIIB/IV Non-Small Cell Lung Cancer
Condition: Non Small Cell Lung Cancer
Interventions: Drug: Cisplatin & Gemcitabine;   Drug: Cisplatin & Pemetrexed;   Drug: Docetaxel & Gemcitabine;   Drug: Pemetrexed & Gemcitabine

Indicates status has not been verified in more than two years